Research and Innovation
Pioneering liposome research, GMPriority Pharma’s state-of-the-art production centre is focused on providing research, development and manufacturing expertise in the production of lipid-based nanoparticles, also known as liposomes.
Our clients and partners range from the academic and industrial sectors through to commercial brands and medical research facilities. We invest heavily in Research & Development, ranging from immunological research to vitamin supplements and medical nutrition.
GMPP originally started as a commercial production facility in The Netherlands, producing liposomal food supplements for the consumer market. More recently, we have expanded into contract research and development, working on patent process work for clients in government, pharmaceutical, biotechnology and medical devices sectors.
We have extensive collaboration history with academic research laboratories and are currently working in partnership with a major university in the development of new anti-tumour compounds which require a liposome delivery system in order to be dosed in vivo.